flow trial semaglutide all-cause mortality hazard ratio Effects of with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the Frontiers | Effects of subcutaneous

Metformin is first-line treatment for type 2 diabetes, but glifozins and Incretin mimetics may be preferred over Gliptins as add-on therapy based on reductions in all-cause and CV mortality

The preclinical and animal studies indicate benefits for tendon and joint injuries, says Drew Timmermans, ND, a naturopathic physician and cofounder of Regenerative Performance in Arizona

When you visit our clinic, we evaluate your medical history, your specific injury or inflammation markers, and your lifestyle goals to determine the correct path

Canadian Medical Association Journal, 196 (43), E1413

The medication makes it easier to eat less, but it doesnt choose what you eat

Many of the studies had small sample size and assessed only short-term outcomes